Ignite Creation Date:
2024-05-06 @ 10:45 AM
Last Modification Date:
2024-10-26 @ 12:35 PM
Study NCT ID:
NCT03347396
Status:
COMPLETED
Last Update Posted:
2022-10-31
First Post:
2017-11-16
Brief Title:
A Study to Assess the Efficacy and Safety of BIVV009 Sutimlimab in Participants With Primary Cold Agglutinin Disease Who Have a Recent History of Blood Transfusion Cardinal Study
Sponsor:
Bioverativ a Sanofi company
Organization:
Sanofi
Organization Data
Organization:
Sanofi
Class:
INDUSTRY
Study ID:
EFC16215
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Bioverativ a Sanofi company
Lead Sponsor Class:
INDUSTRY
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None